CRMD News and Press, CorMedix Inc. From 04/10/21

Today we look at CorMedix, whose shares have had a wild ride thanks primarily to the CRL it received from the FDA around its primary drug candidate. The CRL is likely to be resolved, but does that mean investors should buy the dip in this stock? A full analysis on CorMedix and our...

BERKELEY HEIGHTS, N.J., April 07, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that CorMedix manageme...

Image source: The Motley Fool. CorMedix Inc Common Stock (NASDAQ: CRMD) Q4 2020 Earnings Call Mar 30, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: CorMedix Inc Common Stock (CRMD) Q4 2020 Earnings Call Transcript...

CorMedix Inc. (CRMD) Q4 2020 Earnings Conference Call March 30, 2021 04:30 PM ET Company Participants Dan Ferry - Investor Relations Khoso Baluch - Chief Executive Officer Phoebe Mounts - Executive Vice President & General Counsel Matt David - Executive Vice President & Chief Financia...

Gainers: [[ELOX]] +19.9%. [[SURF]] +15.0%. [[EVK]] +14.3%. [[EQ]] +10.4%. [[HYFM]] +9.2%.Losers: [[EDAP]] -7.4%. [[IMVT]] -5.3%. [[BYND]] -4.8%. [[CRMD]] -4.8%. [[OSMT]] -3.7%. For further details see: ELOX, SURF, EDAP and IMVT among after-hours movers

CorMedix (CRMD): Q4 GAAP EPS of -$0.19 beats by $0.03.Net loss of $6.1MRevenue of $0.06M (+200.0% Y/Y) beats by $0.02M.Khoso Baluch, CorMedix CEO commented, “While we were disappointed that the DefenCath NDA was not approved at its PDUFA date, we remain confident in our efforts to brin...

BERKELEY HEIGHTS, N.J., March 30, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced financial results for ...

Gainers: [[TLS]] +21.3%. [[IMMP]] +13.1%. [[PRTK]] +6.5%. [[WIMI]] +3.8%. [[YY]] +3.4%.Losers: [[CRMD]] -8.9%. [[SYBX]] -5.3%. [[PRQR]] -4.7%. [[CD]] -4.6%. [[OLK]] -3.9%. For further details see: TLS, IMMP, CRMD and SYBX among after-hours movers

BERKELEY HEIGHTS, N.J., March 23, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will report it...

BERKELEY HEIGHTS, N.J., March 15, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it has been appro...